Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 203
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
MindMed Announces Transitions to Management Team
COMPASS Patent Challenge Targets Crystallography Errors
PT279 – Joe Zap & Kevin Whalen – Cannabis Acceptance, Conspiratorial...
PTSF90 – Colorado’s Natural Medicine Healing Act and Guidelines for Emergency...
Numinus Wellness Commends Health Canada on Special Access Programme Amendments to...
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital...
https://www.globenewswire.com/news-release/2021/12/21/2355961/0/en/PharmaTher-Provides-Update-on-Product-Pipeline-and-Expected-Milestones-for-2022.html
Lobe Sciences Announces Publication of PCT Patent Application for Its Combination...
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel
Load more